HEPTAVAC P PLUS SUSPENSION INYECTABLE PARA OVINO
HEPTAVAC P PLUS SUSPENSION INYECTABLE PARA OVINO
Authorised
- Clostridium septicum, toxoid
- Clostridium novyi, toxoid
- Clostridium chauvoei, Inactivated
- Mannheimia haemolytica, Inactivated
- Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
- Clostridium perfringens, type C, beta1 toxoid
- Clostridium tetani, toxoid
- Clostridium perfringens, type D, epsilon toxoid
Product identification
Medicine name:
HEPTAVAC P PLUS SUSPENSION INYECTABLE PARA OVINO
Active substance:
- Clostridium septicum, toxoid
- Clostridium novyi, toxoid
- Clostridium chauvoei, Inactivated
- Mannheimia haemolytica, Inactivated
- Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
- Clostridium perfringens, type C, beta1 toxoid
- Clostridium tetani, toxoid
- Clostridium perfringens, type D, epsilon toxoid
Target species:
-
Sheep
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Clostridium septicum, toxoid2.50/international unit(s)2.00millilitre(s)
-
Clostridium novyi, toxoid3.50/international unit(s)2.00millilitre(s)
-
Clostridium chauvoei, Inactivated1.00/Protective Dose2.00millilitre(s)
-
Mannheimia haemolytica, Inactivated9.00/relative potency2.00millilitre(s)
-
Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated9.00/relative potency2.00millilitre(s)
-
Clostridium perfringens, type C, beta1 toxoid10.00/international unit(s)2.00millilitre(s)
-
Clostridium tetani, toxoid2.50/international unit(s)2.00millilitre(s)
-
Clostridium perfringens, type D, epsilon toxoid5.00/international unit(s)2.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Sheep
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI04AB05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Spanish Agency For Medicines And Medical Devices
Authorisation number:
- 3425 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 15/02/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 15/02/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 15/02/2024